美股详情

本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

NewcelX Ltd.

7.29

-0.3300-4.33%

盘后：6.91-0.3800-5.21%19:59 EDT

成交量：124.69万

成交额：741.72万

市值：3,323.07万

市盈率：-0.28

高：7.64

开：5.08

低：4.20

收：7.62

52周最高：47.40

52周最低：4.20

股本：455.84万

流通股本：455.84万

量比：0.10

换手率：27.35%

股息：- -

股息率：- -

每股收益(TTM):-26.2880

每股收益(LYR):-26.2880

净资产收益率：--

总资产收益率：--

市净率：--

市盈率(LYR):-0.28

数据加载中...

总览公司新闻公告

公司资料

公司名字：

NewcelX Ltd.

交易所：

NASDAQ

成立时间：

2008

员工人数：

13

公司地址：

Pinchas Sapir 7,Ness Ziona,Israel

官网：

http://www.nlspharma.com

邮编：

74140

电话：

972 73 797 1600

传真：

972 8 910 0698

简介：

NLS Pharmaceutics Ltd.于2015年6月成立。该公司是一家创新的生物制药公司，致力于发现和开发可改善罕见中枢神经系统疾病的改善生命的药物疗法。

董事

名称

职位

Ronen Twito

Executive Chairman and Chief Executive Officer

Eran Iohan

Independent Director

Liora Oren

Independent Director

Michel Revel

Chief Scientific Officer and Director

Olivier Samuel

Independent Director

Alexander Zwyer

Director

Tammy Galili

Director

股东

名称

职位

Ronen Twito

Executive Chairman and Chief Executive Officer

Uri Ben Or

Chief Financial Officer

Ariel Revel

Director of Medical Affairs

Eric Konofal

Chief Scientific Officer

Kfir Molakandov

Vice President of Research and Development

Michel Revel

Chief Scientific Officer and Director

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hans/stock/NCEL/company"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"NCEL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCEL\",,,,,undefined,":{"symbol":"NCEL","market":"US","secType":"STK","nameCN":"NewcelX Ltd.","latestPrice":7.29,"timestamp":1761940800000,"preClose":7.62,"halted":0,"volume":1246926,"hourTrading":{"tag":"盘后","latestPrice":6.91,"preClose":7.29,"latestTime":"19:59 EDT","volume":47718,"amount":345479.7893,"timestamp":1761955177846},"delay":0,"floatShares":4558400,"shares":4558400,"eps":-26.28804,"marketStatus":"已收盘","change":-0.33,"latestTime":"10-31 16:00:00 EDT","open":5.08,"high":7.64,"low":4.2,"amount":7417237.8112236,"amplitude":0.451444,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-26.28804,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1762160400000},"marketStatusCode":5,"adr":0,"listingDate":1611896400000,"exchange":"NASDAQ","adjPreClose":7.62,"preHourTrading":{"tag":"盘前","latestPrice":5.26,"preClose":7.62,"latestTime":"09:29 EDT","volume":179418,"amount":1052985.1519248,"timestamp":1761917396617},"postHourTrading":{"tag":"盘后","latestPrice":6.91,"preClose":7.29,"latestTime":"19:59 EDT","volume":47718,"amount":345479.7893,"timestamp":1761955177846},"volumeRatio":0.10434},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"NCEL\",,,,,undefined,":{"symbol":"NCEL","floatShares":4558400,"roa":"--","roe":"--","lyrEps":-26.28804,"volumeRatio":0.10434,"shares":4558400,"dividePrice":0,"high":7.64,"amplitude":0.451444,"preClose":7.62,"low":4.2,"week52Low":4.2,"pbRate":"--","week52High":47.4,"institutionHeld":0,"latestPrice":7.29,"eps":-26.28804,"divideRate":0,"volume":1246926,"delay":0,"ttmEps":-26.28804,"open":5.08,"prevYearClose":2.11,"prevWeekClose":1.3,"prevMonthClose":1.83,"prevQuarterClose":1.83,"fiveDayClose":1.3,"twentyDayClose":1.995,"sixtyDayClose":2.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/NCEL\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-10-31","symbol":"NCEL","defaultRemindTime":1761917400000,"type":"split","dateTimestamp":1761883200000,"forFactor":10,"toFactor":1,"ratio":10},{"market":"US","date":"2025-05-16","symbol":"NCEL","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"盘后","type":"earning","dateTimestamp":1747368000000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2024-09-27","symbol":"NCEL","defaultRemindTime":1727443800000,"type":"split","dateTimestamp":1727409600000,"forFactor":40,"toFactor":1,"ratio":40}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"NCEL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"NCEL\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":224505747,"yearFounded":2008,"employeeNum":13,"address":"Pinchas Sapir 7,Ness Ziona,Israel","zipCode":"74140","officePhone":"972 73 797 1600","officeFax":"972 8 910 0698"},"stockCompanyDetail":{"websiteUrl":"http://www.nlspharma.com","compareEarnings":[{"period":"1week","weight":0.012},{"period":"1month","weight":0.0205},{"period":"3month","weight":0.0935},{"period":"6month","weight":0.1995},{"period":"1year","weight":0.1721},{"period":"ytd","weight":0.16}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"NLS Pharmaceutics Ltd.于2015年6月成立。 该公司是一家创新的生物制药公司，致力于发现和开发可改善罕见中枢神经系统疾病的改善生命的药物疗法。","exchange":"NASDAQ","name":"NewcelX Ltd.","nameEN":"NewcelX Ltd."}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"NCEL\",market:\"US\",,,undefined,":{"directors":[{"name":"Ronen Twito","position":"Executive Chairman and Chief Executive Officer"},{"name":"Eran Iohan","position":"Independent Director"},{"name":"Liora Oren","position":"Independent Director"},{"name":"Michel Revel","position":"Chief Scientific Officer and Director"},{"name":"Olivier Samuel","position":"Independent Director"},{"name":"Alexander Zwyer","position":"Director"},{"name":"Tammy Galili","position":"Director"}],"executives":[{"name":"Ronen Twito","position":"Executive Chairman and Chief Executive Officer"},{"name":"Uri Ben Or","position":"Chief Financial Officer"},{"name":"Ariel Revel","position":"Director of Medical Affairs"},{"name":"Eric Konofal","position":"Chief Scientific Officer"},{"name":"Kfir Molakandov","position":"Vice President of Research and Development"},{"name":"Michel Revel","position":"Chief Scientific Officer and Director"}]}}}